GSA Capital Partners LLP Has $363,000 Position in Hill-Rom Holdings, Inc. (HRC)

Share on StockTwits

GSA Capital Partners LLP lowered its stake in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) by 84.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 4,154 shares of the medical technology company’s stock after selling 23,161 shares during the quarter. GSA Capital Partners LLP’s holdings in Hill-Rom were worth $363,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Mutual of America Capital Management LLC boosted its holdings in Hill-Rom by 3.6% during the 2nd quarter. Mutual of America Capital Management LLC now owns 67,718 shares of the medical technology company’s stock valued at $5,914,000 after acquiring an additional 2,323 shares during the period. Martingale Asset Management L P boosted its holdings in Hill-Rom by 2.0% during the 2nd quarter. Martingale Asset Management L P now owns 477,667 shares of the medical technology company’s stock valued at $41,720,000 after acquiring an additional 9,200 shares during the period. Front Barnett Associates LLC boosted its holdings in Hill-Rom by 43.9% during the 2nd quarter. Front Barnett Associates LLC now owns 29,277 shares of the medical technology company’s stock valued at $2,557,000 after acquiring an additional 8,927 shares during the period. American International Group Inc. boosted its holdings in Hill-Rom by 0.9% during the 2nd quarter. American International Group Inc. now owns 133,629 shares of the medical technology company’s stock valued at $11,671,000 after acquiring an additional 1,136 shares during the period. Finally, Trexquant Investment LP boosted its holdings in Hill-Rom by 187.3% during the 2nd quarter. Trexquant Investment LP now owns 8,612 shares of the medical technology company’s stock valued at $752,000 after acquiring an additional 5,614 shares during the period. 84.83% of the stock is currently owned by hedge funds and other institutional investors.

Several equities research analysts have weighed in on HRC shares. ValuEngine upgraded Hill-Rom from a “hold” rating to a “buy” rating in a report on Tuesday, July 31st. KeyCorp upped their target price on Hill-Rom from $97.00 to $115.00 and gave the stock an “overweight” rating in a report on Tuesday, July 17th. Northcoast Research reiterated a “buy” rating and issued a $104.00 target price on shares of Hill-Rom in a report on Tuesday, July 31st. Morgan Stanley upped their target price on Hill-Rom from $95.00 to $100.00 and gave the stock an “equal weight” rating in a report on Thursday. Finally, Zacks Investment Research cut Hill-Rom from a “buy” rating to a “hold” rating in a report on Wednesday, August 1st. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $100.00.

Shares of NYSE HRC traded up $0.94 during mid-day trading on Friday, reaching $88.21. 764,108 shares of the company were exchanged, compared to its average volume of 454,661. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.58 and a quick ratio of 1.18. The stock has a market capitalization of $6.27 billion, a P/E ratio of 22.85, a price-to-earnings-growth ratio of 1.47 and a beta of 0.89. Hill-Rom Holdings, Inc. has a 1 year low of $75.21 and a 1 year high of $98.96.

Hill-Rom (NYSE:HRC) last issued its quarterly earnings data on Friday, July 27th. The medical technology company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.13 by $0.02. Hill-Rom had a return on equity of 20.54% and a net margin of 8.19%. The firm had revenue of $708.60 million during the quarter, compared to analysts’ expectations of $707.50 million. During the same period in the prior year, the business posted $0.91 EPS. The firm’s quarterly revenue was up 2.8% on a year-over-year basis. As a group, equities research analysts anticipate that Hill-Rom Holdings, Inc. will post 4.64 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, September 28th. Investors of record on Friday, September 21st were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 0.91%. The ex-dividend date of this dividend was Thursday, September 20th. Hill-Rom’s dividend payout ratio is currently 20.73%.

About Hill-Rom

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Read More: How to Track your Portfolio in Google Finance

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.